Abstract:More than 2 decades of developments in the field have led to a wide variety of test kits available for addressing the different needs of surveillance, diagnosis, and monitoring of human immunodeficiency virus (HIV) infection and antiretroviral therapy (20, 23). These test kits are based on different tech- nologies, including immunoassays and molecular testing. Typ- ically, enzyme-linked immunosorbent assays (ELISAs) and rapid tests for detecting anti-HIV antibodies are used for blood screening and/or surveillance purposes. The former in- clude third-generation ELISAs that utilize the antigen sand- wich design for improved sensitivity, while the latter term re- fers to immunochromatographic tests or other simple antibody tests requiring less than 30 min of assay time. Since the viral capsid (core) p24 protein can be detected earlier than anti- HIV antibodies (93), attempts had also been made to develop a new generation of ELISA capable of simultaneously detect- ing the p24 antigen and anti-HIV antibodies (34, 52, 76, 101, 103). Significant reductions of the window period were achieved, which is ideal for blood screening and surveillance (102), but users were also advised to be mindful of possible limitations when utilizing such a combination assay (52, 81, 83). With specific panels, a delay in detection by a fourth- generation ELISA was evident compared with a dedicated p24 antigen assay (81). This shortcoming of fourth-generation ELISAs is understandable, because the surface area of the solid phase for detection is constant and limited regardless of whether it is utilized for a single test or combined assays (101). It should also be noted that an additional procedure for the dissociation of immune complexes employed by dedicated p24 antigen assays but not by combined assays was found to facil- itate sensitive detection (85). However, this does not mean that using ELISA dedicated for detecting p24 antigen has no short- comings. The viral p24 protein is a transient marker that can fall to an undetectable level after initial acute infection and only reemerges at the advanced stage of AIDS in patients (93, 107). Hence, tests utilizing this marker are more valuable for situations such as screening blood products from individuals before antibodies are produced, detecting early infections in persons who have been exposed but are seronegative, or mon-

57 Samples Antibody Detection of HIV by Western Blot

Hiv-1 Antibody Testing Strategy - Evaluation of Elisa Screening and Western Blot Profiles in A Mixed Low-Risk High-Risk Patient Population

Anti-HIV-1 antibodies based confirmatory results in Wuhan, China, 2012-2018

Development and Evaluation of A Line Immunoassay As A Confirmatory Test for Human Immunodeficiency Virus (Hiv)-1/2 Infections

Reassessing of Samples with Weak Coloration by Anti-Hiv with ELISA

Evaluation of HIV Antibody Diagnosis Reagents Used in Shandong Province in 2005

Detection of immunological and serological indicator of HIV-1 infected individuals

Application of automatic Western blot detection system in HIV antibody confirmatory test

Detection and Clinical Significance of HIV-1 Antibody in Urine

Evaluation of 30 Commercial Assays for the Detection of Antibodies to Hiv in China Using Classical and Bayesian Statistics

Frequency, causes, and new challenges of indeterminate results in Western blot confirmatory testing for antibodies to human immunodeficiency virus.

Assessment of 136 samples which were positive by routine HIV1+2 antibody screening test and negative by WB assay

TESTING EVALUATION OF HIV ANTIBODY DIAGNOSTIC REAGENTS IN SHANDONG PROVINCE

Analysis on western blot patterns for HIV-1 antibody positive cases in Beijing

The Characteristics of Screening and Confirmatory Test Results for Hiv in Xi'An, China

Evaluation of the Repeatability and Stability of Limiting-Antigen Avidity Enzyme Immunoassay for HIV-1 Incidence Estimates

Screening and follow-up of the indeterminate samples by HIV antibody confirmation test

Screening Assay for Human Immunodeficiency Virus Infection with VIDAS(R) HIV DUO Ultra

Prevalence of HIV Indeterminate Western Blot Tests and Follow-up of HIV Antibody Sero-Conversion in Southeastern China

The Evaluation of Elecsys HIV Combi Reagent in Detecting HIV Antigen and Antibody

The False-Positive And False-Negative Predictive Value Of Hiv Antibody Test In The Chinese Population